Eisai has filed to extend the label for its Alzheimer’s disease therapy Leqembi to include a maintenance dosing regimen that would reduce the number of intravenous infusions needed to one per month.

SurePoint Technologies Chief Market Strategy Officer: Cultural Resistance, Lack of Integration Hindering Legal Innovation Olivia Mockel, chief brand and market strategy officer at SurePoint ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

Formlabs announced two new 3D printers, the Form 4L and Form 4BL. The company had previously announced the Form 4, a major change from their prior flagship machine, the Form 3. The new Form 4L ...

We’ve been testing the brand-new Formlabs 4L 3D printer in the past few weeks, and we’d like to tell you about it. This is part one of a three-part series; please read parts two and three. Formlabs ...